Roche Holding AG
http://www.roche.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Roche Holding AG
Roche On Track To Supplement Relaunched Susvimo’s Label
Having relaunched Susvimo for wet AMD, Roche now has the ocular implant under FDA review for approval in two diabetic ophthalmic indications and presented two-year data in those settings.
Relay’s SHP2 Runs Aground As Roche Pulls Out Of Development Deal
Relay said in an SEC filing that Roche terminated the deal to develop migoprotafib, though Roche emphasized that it was not due to any emerging clinical safety concerns.
Roche Could Have The Best Obesity Pill
That is, if very early data in a handful of patients are borne out in later, larger studies.
CordenPharma Will Scale Up To Address GLP-1 Shortage
The Swiss contractor said it will invest about $981m to increase manufacturing capacity for GLP-1 peptides in the US and EU, to fulfill API contracts worth more than $3bn.
Company Information
- Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
-
- Adheron Therapeutics
- Anadys Pharmaceuticals, Inc.
- Ariosa Diagnostics
- Arius Research, Inc.
- Boehringer Mannheim
- CAPP Medical
- Chugai Pharmaceutical Co., Ltd.
- Dutalys GmbH
- Flatiron Health
- Foundation Medicine
- GenMark Diagnostics, Inc.
- Genentech Inc.
- GeneWEAVE BioSciences, Inc.
- Genia Technologies, Inc.
- GlycArt Biotechnology
- Hoffmann-La Roche
- Inflazome Ltd.
- Ignyta, Inc. (RXDX) (Actagene Oncology, Inc
- NexDx, Inc.)
- Inception 5
- InterMune, Inc.
- Inflazome Ltd.
- IQuum, Inc.
- Jecure Therapeutics
- Kapa Biosystems, Inc.
- Marcadia Biotech, Inc.
- Medingo Ltd.
- Memory Pharmaceuticals Corporation
- mtm laboratories AG
- Piramed Pharma
- Santaris Pharma A/S
- Seragon Pharmaceuticals
- Signature Diagnostics AG
- Stratos Genomics
- Syntex Corporation
- Tanox, Inc.
- Tensha Therapeutics, Trophos SA
- Ventana Medical Systems, Inc.
- Viewics, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice